Javascript must be enabled to continue!
Glucose responsive neurons in the nucleus of the solitary tract are responsive to nesfatin‐1 (1126.3)
View through CrossRef
Nesfatin‐1 (nes‐1) exerts important effects on food intake and glucose handling and is expressed in the nucleus of the solitary tract (NTS), a critical medullary autonomic control center. Since hypoglycemia induces cFos expression in nes‐1 immunoreactive NTS neurons, here we examined effects of nes‐1 on the excitability of glucose responsive NTS cells using whole‐cell patch clamp recordings. A total of 44% of neurons tested (7/16) responded to a decrease from 3 to 0.2 mM glucose, 4 with a depolarization (glucose inhibited (GI), mean 6.1 ± 1.6 mV), and 3 with a hyperpolarization (glucose excited (GE), mean ‐5.7 ± 1.4 mV). Bath applied nes‐1 (10 nM) influenced the excitability of all but one of these glucose responsive neurons. All GI neurons responded to nes‐1, 3 with a depolarization (mean 7.6 ± 2.4 mV) and 1 with a hyperpolarization (‐8.5 mV). Moreover, 2/3 GE cells were depolarized by nes‐1 (mean 3.3 ± 1.0 mV) while 1 did not respond. NTS neurons which did not respond to changes in glucose (9/16) were also nes‐1 responsive, with 5 showing a depolarization (mean 3.5 ± 0.4 mV) and 4 a hyperpolarization (mean ‐5.8 ± 0.5 mV). While our findings reveal clear actions of nes‐1 on glucose sensing NTS neurons, they do not suggest functional differentiation between the effects of nes‐1 on GI and GE neurons. Our observations lend further support to the hypothesis that nes‐1 may act as a locally released modulator of intrinsic neuronal function.
Grant Funding Source
: NSERC, FQRNT, HSFO
Title: Glucose responsive neurons in the nucleus of the solitary tract are responsive to nesfatin‐1 (1126.3)
Description:
Nesfatin‐1 (nes‐1) exerts important effects on food intake and glucose handling and is expressed in the nucleus of the solitary tract (NTS), a critical medullary autonomic control center.
Since hypoglycemia induces cFos expression in nes‐1 immunoreactive NTS neurons, here we examined effects of nes‐1 on the excitability of glucose responsive NTS cells using whole‐cell patch clamp recordings.
A total of 44% of neurons tested (7/16) responded to a decrease from 3 to 0.
2 mM glucose, 4 with a depolarization (glucose inhibited (GI), mean 6.
1 ± 1.
6 mV), and 3 with a hyperpolarization (glucose excited (GE), mean ‐5.
7 ± 1.
4 mV).
Bath applied nes‐1 (10 nM) influenced the excitability of all but one of these glucose responsive neurons.
All GI neurons responded to nes‐1, 3 with a depolarization (mean 7.
6 ± 2.
4 mV) and 1 with a hyperpolarization (‐8.
5 mV).
Moreover, 2/3 GE cells were depolarized by nes‐1 (mean 3.
3 ± 1.
0 mV) while 1 did not respond.
NTS neurons which did not respond to changes in glucose (9/16) were also nes‐1 responsive, with 5 showing a depolarization (mean 3.
5 ± 0.
4 mV) and 4 a hyperpolarization (mean ‐5.
8 ± 0.
5 mV).
While our findings reveal clear actions of nes‐1 on glucose sensing NTS neurons, they do not suggest functional differentiation between the effects of nes‐1 on GI and GE neurons.
Our observations lend further support to the hypothesis that nes‐1 may act as a locally released modulator of intrinsic neuronal function.
Grant Funding Source
: NSERC, FQRNT, HSFO.
Related Results
Evidence of Nesfatin-1 in Mouse Intestinal Enteroendocrine Cells
Evidence of Nesfatin-1 in Mouse Intestinal Enteroendocrine Cells
Objectives: Post-prandial insulin secretion is predominantly regulated by four intestinal hormones: glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (G...
Correlation of serum Nesfatin 1 level with metabolic and clinical parameters in Indian women with and without polycystic ovarian syndrome
Correlation of serum Nesfatin 1 level with metabolic and clinical parameters in Indian women with and without polycystic ovarian syndrome
Abstract
ObjectiveTo compare serum Nesfatin 1 levels in Indian women with and without PCOS and to evaluate the association of serum Nesfatin 1 with metabolic and clinical p...
Associations between serum JAML, nesfatin-1, and 25(OH)D and the risk of diabetic kidney disease in patients with type 2 diabetes
Associations between serum JAML, nesfatin-1, and 25(OH)D and the risk of diabetic kidney disease in patients with type 2 diabetes
Abstract
This study was designed to assess the associations between serum junctional adhesion molecule-like protein (JAML), nesfatin-1, and 25-hydroxy vitamin D (25(OH)D) a...
Whole-Body Loss of NUCB2/Nesfatin-1 Alters Enteric Hormone Expression
Whole-Body Loss of NUCB2/Nesfatin-1 Alters Enteric Hormone Expression
Objectives: Post-prandial insulin secretion is predominantly regulated by four intestinal hormones: glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (G...
Copeptin and Nesfatin-1 are interesting interrelated biomarkers playing a role in the pathogenesis of insulin resistance in Chinese obese children
Copeptin and Nesfatin-1 are interesting interrelated biomarkers playing a role in the pathogenesis of insulin resistance in Chinese obese children
Abstract
Background Recently, copeptin and nesfatin-1 have been identified as interesting novel peptides playing a role in the pathogenesis of obesity-related insulin resis...
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Abstract
Introduction
During pregnancy, women may develop blood glucose abnormalities like gestational diabetes mellitus (GDM) or, rarely, type 1 diabetes (T1D), which can lead to ...
Effect of Biochanin A on Serum Nesfatin-1 Level in STZ Induced Type 1 Diabetic Rat
Effect of Biochanin A on Serum Nesfatin-1 Level in STZ Induced Type 1 Diabetic Rat
recognized as a regulatory peptide, which can increase insulin sensitivity and affect glucose metabolism. In this study, effects of BCA, on serum nesfatin-1 level were examined in ...
697. EXPLORING THE POTENTIAL OF GUT TASTE RECEPTORS FOR THE TREATMENT OF DISORDERED EATING BEHAVIOUR
697. EXPLORING THE POTENTIAL OF GUT TASTE RECEPTORS FOR THE TREATMENT OF DISORDERED EATING BEHAVIOUR
Abstract
Background
Individuals who suffer from disordered overeating often experience dysregulated food reward. As such, invest...

